Effect of oral anticoagulation on left atrial appendage thrombus resolution in patients with rheumatic mitral stenosis: A prospective observational study.

Praveen  Kumar; Ravi Vishnu  Prasad

doi:10.51168/sjhrafrica.v6i12.2323

Authors

Praveen Kumar DM Resident, Department of Cardiology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
Ravi Vishnu Prasad Professor and Head, Department of Cardiology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India

DOI:

https://doi.org/10.51168/sjhrafrica.v6i12.2323

Keywords:

Rheumatic mitral stenosis, Left atrial appendage thrombus, Oral anticoagulation, Transesophageal echocardiography, Acenocoumarol

Abstract

Background:
Rheumatic mitral stenosis (MS) remains a major cause of cardiovascular morbidity in developing countries and is frequently complicated by atrial fibrillation and left atrial appendage (LAA) thrombus formation. The presence of LAA thrombus significantly increases thromboembolic risk and contraindicates interventional procedures such as percutaneous transvenous mitral commissurotomy (PTMC).

Objectives:
To evaluate the effect of oral anticoagulation on the resolution of left atrial appendage thrombus in patients with rheumatic mitral stenosis and to identify clinical and echocardiographic predictors of thrombus clearance.

Methods:
This prospective hospital-based observational study was conducted in the Department of Cardiology, Indira Gandhi Institute of Medical Sciences, Patna. Thirty patients with severe isolated rheumatic mitral stenosis and documented LAA thrombus on transesophageal echocardiography (TEE) were enrolled. All patients received oral anticoagulation with acenocoumarol and were followed for 12 weeks with weekly INR monitoring, targeting a therapeutic range of 2.0–2.5.

Results:
Most patients were young adults with a female predominance, and atrial fibrillation was present in 73.3%. Oral anticoagulation led to a significant reduction in mean LAA thrombus size from 5.34 ± 4.42 cm² at baseline to 3.82 ± 4.03 cm² after treatment. A substantial proportion of patients achieved complete thrombus resolution, while others demonstrated partial clearance. Reduction in spontaneous echo contrast intensity was also observed. Thrombus resolution was more likely in patients with smaller baseline thrombus size, sinus rhythm, lower left atrial dimensions, higher LAA emptying velocities, and sustained therapeutic INR levels.

Conclusion:
Oral anticoagulation with acenocoumarol is effective in achieving complete or partial resolution of left atrial appendage thrombus in patients with rheumatic mitral stenosis. Adequate INR control and favorable echocardiographic parameters play a critical role in thrombus clearance.

Recommendation:
Structured vitamin K antagonist therapy with strict INR monitoring and repeat transesophageal echocardiography should be routinely employed before considering interventional procedures in this high-risk population.

References

Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet infectious diseases. 2005 Nov 1;5(11):685-94. https://doi.org/10.1016/S1473-3099(05)70267-X

Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, Mauff K, Islam S, Joachim A, Daniels R, Francis V. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). European Heart Journal. 2015 May 7;36(18):1115-22. https://doi.org/10.1093/eurheartj/ehu449

Deedwania P, Chowdhury S, Ravi MS, Sawhney JP, Bagga S, Sawhney S, Iyengar SS, Pancholia AK. Section 2: Dyslipidemia.

Karthikeyan G. Stroke risk in rheumatic heart disease. Heart. 2021 May 1;107(9):694-6. https://doi.org/10.1136/heartjnl-2020-318756

Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast, and thromboembolic risk in vivo. Journal of the American College of Cardiology. 1994 Mar 15;23(4):961-9. https://doi.org/10.1016/0735-1097(94)90644-0

Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT, Mayosi BM, Mensah GA, Nascimento BR. Global, regional, and national burden of rheumatic heart disease, 1990-2015. New england journal of medicine. 2017 Aug 24;377(8):713-22. https://doi.org/10.1056/NEJMoa1603693

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010 Feb 1;137(2):263-72. https://doi.org/10.1378/chest.09-1584

Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. New England Journal of Medicine. 2001 May 10;344(19):1411-20. https://doi.org/10.1056/NEJM200105103441901

Romero J, Husain SA, Kelesidis I, Sanz J, Medina HM, Garcia MJ. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis. Circulation: Cardiovascular Imaging. 2013 Mar;6(2):185-94. https://doi.org/10.1161/CIRCIMAGING.112.000153

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2017 Jul 11;70(2):252-89. https://doi.org/10.1016/j.jacc.2017.03.011

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S. Dabigatran versus warfarin in patients with atrial fibrillation. New England journal of medicine. 2009 Sep 17;361(12):1139-51. https://doi.org/10.1056/NEJMoa0905561

Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R. Dabigatran versus warfarin in patients with mechanical heart valves. New England Journal of Medicine. 2013 Sep 26;369(13):1206-14. https://doi.org/10.1056/NEJMoa1300615

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. The Lancet. 2014 Mar 15;383(9921):955-62. https://doi.org/10.1016/S0140-6736(13)62343-0

Iung B, Vahanian A. Rheumatic and calcific mitral stenosis and mitral commisurotomy. Valvular heart disease: a companion to Braunwald's heart disease. 5th ed. Philadelphia: Elsevier. 2020 Jun 10:311-6.

North PE, Ziegler E, Mahnke DK, Stamm KD, Thomm A, Daft P, Goetsch M, Liang HL, Baker MA, Vepraskas A, Rosenau C. Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability. PLoS One. 2020 Jan 13;15(1):e0227385. https://doi.org/10.1371/journal.pone.0227385

Chopra HK, Nanda NC, Narula J. Advances in Clinical Cardiovascular Imaging, Echocardiography & Interventions: A Textbook of Cardiology.

Corrado G, Tadeo G, Beretta S, Tagliagambe LM, Manzillo GF, Spata M, Santarone M. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation: a transesophageal echocardiographic study. Chest. 1999 Jan 1;115(1):140-3. https://doi.org/10.1378/chest.115.1.140

Weitz JI, Eikelboom JW, Samama MM. New antithrombotic drugs: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb 1;141(2):e120S-51S. https://doi.org/10.1378/chest.11-2294

Developed with the Special Contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal. 2010 Oct 1;31(19):2369-429.

Weigner MJ, Thomas LR, Patel U, Schwartz JG, Burger AJ, Douglas PS, Silverman DI, Manning WJ. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year. The American journal of medicine. 2001 Jun 15;110(9):694-702. https://doi.org/10.1016/S0002-9343(01)00716-1

Padmavati S. Epidemiology of cardiovascular disease in India: I. Rheumatic heart disease. Circulation. 1962 Apr;25(4):703-10. https://doi.org/10.1161/01.CIR.25.4.703

Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. The Lancet. 2005 Jul 9;366(9480):155-68. https://doi.org/10.1016/S0140-6736(05)66874-2

Zühlke LJ, Beaton A, Engel ME, Hugo-Hamman CT, Karthikeyan G, Katzenellenbogen JM, Ntusi N, Ralph AP, Saxena A, Smeesters PR, Watkins D. Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations. Current treatment options in cardiovascular medicine. 2017 Feb;19(2):15. https://doi.org/10.1007/s11936-017-0513-y

Lip GY, Lane DA. Stroke prevention in atrial fibrillation: a systematic review. Jama. 2015 May 19;313(19):1950-62. https://doi.org/10.1001/jama.2015.4369

Savelieva I, Camm AJ. Practical considerations for using novel oral anticoagulants in patients with atrial fibrillation. Clinical cardiology. 2014 Jan;37(1):32-47. https://doi.org/10.1002/clc.22204

Ayirala S, Kumar S, O'Sullivan DM, Silverman DI. Echocardiographic predictors of left atrial appendage thrombus formation. Journal of the American Society of Echocardiography. 2011 May 1;24(5):499-505. https://doi.org/10.1016/j.echo.2011.02.010

Kim TS, Youn HJ. Role of echocardiography in atrial fibrillation. Journal of Cardiovascular Ultrasound. 2011 Jun 30;19(2):51. https://doi.org/10.4250/jcu.2011.19.2.51

Linefsky JP, Otto CM. Aortic stenosis: clinical presentation, disease stages, and timing of intervention. Valvular heart disease: a companion to Braunwald's heart disease. 5th ed. Philadelphia: Elsevier. 2020 Jun 10:156-78.